Reviewing CVRx (NASDAQ:CVRX) and Meihua International Medical Technologies (NASDAQ:MHUA)

Meihua International Medical Technologies (NASDAQ:MHUA) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Institutional and Insider Ownership

1.2% of Meihua International Medical Technologies shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 66.6% of Meihua International Medical Technologies shares are owned by insiders. Comparatively, 18.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Meihua International Medical Technologies and CVRx’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Meihua International Medical Technologies	$97.10 million	0.17	$11.62 million	N/A	N/A
CVRx	$42.09 million	3.82	-$41.20 million	($2.47)	-3.02

Meihua International Medical Technologies has higher revenue and earnings than CVRx.

Volatility & Risk

Meihua International Medical Technologies has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, CVRx has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Meihua International Medical Technologies and CVRx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Meihua International Medical Technologies	0	0	0	0	N/A
CVRx	0	2	4	0	2.67

CVRx has a consensus target price of $16.60, indicating a potential upside of 122.82%. Given CVRx’s higher possible upside, analysts clearly believe CVRx is more favorable than Meihua International Medical Technologies.

Profitability

This table compares Meihua International Medical Technologies and CVRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Meihua International Medical Technologies	N/A	N/A	N/A
CVRx	-123.58%	-66.05%	-46.99%

Summary

Meihua International Medical Technologies beats CVRx on 6 of the 11 factors compared between the two stocks.

About Meihua International Medical Technologies

Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

About CVRx

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.